Helius Medical Technologies (NASDAQ:HSDT) Releases Earnings Results, Misses Estimates By $0.14 EPS

Helius Medical Technologies (NASDAQ:HSDT) posted its earnings results on Monday. The company reported ($0.64) earnings per share for the quarter, missing the consensus estimate of ($0.50) by ($0.14), Zacks reports. The company had revenue of $0.18 million for the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. During the same period last year, the firm earned ($3.00) earnings per share.

Helius Medical Technologies Price Performance

Shares of Helius Medical Technologies stock traded down $0.05 during trading on Wednesday, reaching $0.70. 35,892 shares of the stock traded hands, compared to its average volume of 326,800. Helius Medical Technologies has a 52-week low of $0.65 and a 52-week high of $13.43. The business has a fifty day simple moving average of $0.91 and a two-hundred day simple moving average of $3.33. The company has a market capitalization of $2.08 million, a price-to-earnings ratio of -0.06 and a beta of 1.60.

About Helius Medical Technologies

Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.